537 related articles for article (PubMed ID: 25525179)
1. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
3. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
4. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
5. Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
Mishima E; Fukuda S; Kanemitsu Y; Saigusa D; Mukawa C; Asaji K; Matsumoto Y; Tsukamoto H; Tachikawa T; Tsukimi T; Fukuda NN; Ho HJ; Kikuchi K; Suzuki C; Nanto F; Suzuki T; Ito S; Soga T; Tomioka Y; Abe T
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F824-F833. PubMed ID: 29167170
[TBL] [Abstract][Full Text] [Related]
6. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
[TBL] [Abstract][Full Text] [Related]
7. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
[TBL] [Abstract][Full Text] [Related]
8. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
9. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
10. Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.
Zhao J; Zhao C; Xun T; Wang X; Wei S; Ye C; Zhang M; Guo D; Yang X
Drug Des Devel Ther; 2024; 18():13-28. PubMed ID: 38205394
[TBL] [Abstract][Full Text] [Related]
11. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
12. Lubiprostone for chronic constipation in adults.
Drug Ther Bull; 2014 Apr; 52(4):42-4. PubMed ID: 24722574
[TBL] [Abstract][Full Text] [Related]
13. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
14. Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone.
Kang DW; DiBaise JK; Ilhan ZE; Crowell MD; Rideout JR; Caporaso JG; Rittmann BE; Krajmalnik-Brown R
Anaerobe; 2015 Jun; 33():33-41. PubMed ID: 25617726
[TBL] [Abstract][Full Text] [Related]
15. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
16. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series.
O'Brien CE; Anderson PJ; Stowe CD
Ann Pharmacother; 2010 Mar; 44(3):577-81. PubMed ID: 20179256
[TBL] [Abstract][Full Text] [Related]
17. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.
Hsu CN; Yang HW; Hou CY; Chang-Chien GP; Lin S; Tain YL
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008046
[TBL] [Abstract][Full Text] [Related]
18. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
19. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
[TBL] [Abstract][Full Text] [Related]
20. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
